NCT02208934
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
- Locations
-
- CIM-Sant Pau - IIB Sant Pau, HSCSP Barcelona, Spain
- Palobiofarma S.L. (molecule owner) Mataró, Barcelona, Spain
Clinical trial condition
Explore clinical trials studying Dementia. Study availability and eligibility vary by location and protocol.
NCT02208934
NCT01320527
NCT01227564
NCT01129115
NCT02361242
NCT02361424
NCT01782742
NCT01699711
NCT01325259
NCT02386306